Se-cure Pharmaceuticals is seeking a strategic partner to collaborate in the development of Femarelle^® into Phase III, as a Botanical Drug for the US market.

For further information, please contact Esti Grunbaum, VP Business Development & Marketing, This e-mail address is being protected from spam bots, you need JavaScript enabled to view it